<unk>  is a central alpha-2-adrenergic agonist that is FDA approved for the {{{indicationType}}} of spasticity.   Common adverse reactions include dry mouth, somnolence, asthenia, dizziness, urinary tract infection, constipation, liver function tests abnormal, vomiting, speech disorder, amblyopia, urinary frequency, flu syndrome, SGPT/ALT increased, dyskinesia, nervousness, pharyngitis, and rhinitis.
Tizanidine
Propanidid
Aceclidine
Meperidine 
Esketamine
Betanidine
Tipepidine
Bromhexine